1Viriyakaosol S, Kirldand T N.The N-terminal half of membrane CD14 is a functional cell lipopolysacccharied receptor[ J]. Infect Immun, 1996, 64(2):653-656.
2Shaoiro R A, Cuningham M D, Ratcliffe K, etal. Identification of CD14 residues invdves in specific lipopolysacceharide recognization [ J ]. Infect Immun, 1997,65 ( 1 ) : 293-297.
3Landmann R,Zimmerli W, Sansano D, et al. Increased circulation soluble CD14 is associated with high mortality in gram-negative shok[ J] .J Infect Dis, 1995,171(3) :639-644.
4Anrditi M, Zhou J, Dorio R, et al. Endotoxin-mediated endothelial cell injury and activation: role of soluble CD14[J]. Infect Immun, 1993,61(8) :3149-3156.
5Viriyakosol S, Kiddand T. Knowledge of cellular rector for bacterial endotofin-1995[ J] .Clin Infect Dis, 1995,21(suppl 2):s190-195.
6Haziot A,Katz I,Rong G W, etal. Evidene that the receptor for soluble CD14: LPS complexes may not be the putative signal-transducing molecule associated with membrane-bound CD14 [ J ]. Scand J Immunol, 1997, 46(3) :242-245.
8Mehta J L, Saldeen T G P, Rand K. Interactive role of infection,inflammation and traditional risk factors in atherosclerosis and coronary artery disease[ J]. J AM Coll Cardid, 1998,31 (6):1217-1225.
9Hubacek J A,Pit'ha J, Skodova Z,et al. C(-260)→T polymorphism in the promoter of the CD14 monocyte receptor gene as a rlak factor for myocardial infarction[ J]. Circulation, 1999,99(25) : 3218-3220.
10Shimada K, Watanabe Y, Mokuno H, et al. Common polymorphism in the promoter of the CD14 monocyte receptor gene is associated with acute myocardial infarction in Japanese men[J]. Am J Cardiol, 2000, 86 (6) : 682-684.
